Fig. 4
A, B Mice with SW1990 tumors were administered 0.8 mg iMN041 SC in FS-19 qod or PBS (n = 10 per group). Mean tumor volume +/- SD at study initiation was 65 mm3 +/- 6.6. A Graph of SW1990 growth in iMN041 treated versus control animals. B Survival proportions in SW1990 implants, treated versus control. (42 vs. 30 days, p < 0.0001). C Mice with CFPAC-1 tumors were initially administered 1.2 mg iMN041 SC in FS-19 qod or PBS (n = 10 per group). Graph of CFPAC-1 growth in iMN041 treated versus vehicle control animals. Mean tumor volume +/- SD at study initiation was 61 mm3 +/- 5.4